Global Vascular Access Device Market Size study & Forecast, by Type (Central vascular access device, Tunneled catheters, Non-tunneled catheters, Implanted ports, Peripherally inserted central catheters, Peripheral vascular access device, Peripheral midlines devices, Peripheral short devices, Butterfly/winged steel needles, Accessories) by Application (Drug administration, Fluid and nutrition administration, Blood transfusion, Diagnostics and testing), by End User (Hospital, Clinics and ambulatory care centers, Other end users) and Regional Analysis, 2023-2030
Global Vascular Access Device Market is valued approximately at USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. A Vascular Access Device (VAD) is a medical device designed to provide access to a patient's bloodstream for various medical treatments, procedures, and interventions. It allows healthcare professionals to administer medications, fluids, nutrients, and blood products, as well as to monitor vital signs and draw blood samples without the need for repeated needle sticks. VADs are particularly useful in situations where long-term or frequent access to the bloodstream is required, such as for patients undergoing chemotherapy, dialysis, or intravenous (IV) therapy. They help to minimize the discomfort and potential complications associated with repeated needle insertions. The key factors driving the market growth is rising prevalence of lifestyle-related disorders, growing number of chemotherapy procedures with high hospitalization rates, and growing aging population that anticipated to support the market growth during forecast period.
Moreover, the growing aging population contributes to the increasing VAD market. The aging individuals are more likely to have multiple medical conditions concurrently, leading to a greater need for medical interventions. These patients might require multiple VADs for different purposes, such as central venous catheters for chemotherapy and peripherally inserted central catheters (PICCs) for antibiotics or nutrition. According to the World Bank, 8% of the total population aged 65 and older lived in the world in 2015, and in 2021 the rate reached 10 %. Additionally, the growing healthcare infrastructure development is anticipated to create the lucrative opportunity for the market growth during forecast period. However, the risks associated with catheter usage and stringent regulations and product recalls stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Vascular Access Device Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising incidence of chronic diseases, increased demand for homecare settings, and growing prevalence of cancer. Whereas, the Asia Pacific is expected to grow with the fastest growth rate during the forecast period, owing to factors such as the increasing healthcare expenditure, growing aging population, rising chronic diseases, and supportive government initiatives that anticipated to support the market growth.
Major market player included in this report are:Teleflex Medical Incorporated
B. Braun
Smiths Medical, Inc. (ICU Medical, Inc)
Cook Group
AngioDynamics
Medtronic plc
Medical Components, Inc.
Cook Medical
Terumo Medical Corporation
Access Vascular, Inc
Recent Developments in the Market: In July 2022, B. Braun Medical Inc. (B. Braun), has launched its new Introcan Safety 2 IV Catheter with one-time blood control. The Introcan Safety 2 IV Catheter is the latest development from B. Braun for making IV access safer for the clinician by reducing the risk of needlestick injuries and their exposure to blood.
Global Vascular Access Device Market Report Scope: Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Type, Application, End User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:By Type:
Central vascular access device
Tunneled catheters
Non-tunneled catheters
Implanted ports
Peripherally inserted central catheters
Peripheral vascular access device Peripheral midlines devices
Peripheral short devices
Butterfly/winged steel needles
Accessories
By Application:
Drug administration
Fluid and nutrition administration
Blood transfusion
Diagnostics and testing
By End User:
Hospital
Clinics and ambulatory care centers
Other end users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Companies MentionedTeleflex Medical Incorporated
B. Braun
Smiths Medical, Inc. (ICU Medical, Inc)
Cook Group
AngioDynamics
Medtronic plc
Medical Components, Inc.
Cook Medical
Terumo Medical Corporation
Access Vascular, Inc
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.